Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke.

Stroke anticoagulation atrial fibrillation paroxysmal atrial fibrillation stroke recurrence sustained atrial fibrillation

Journal

European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 24 02 2018
accepted: 26 05 2018
entrez: 6 6 2019
pubmed: 6 6 2019
medline: 6 6 2019
Statut: ppublish

Résumé

The relationship between different patterns of atrial fibrillation and early recurrence after an acute ischaemic stroke is unclear. In a prospective cohort study, we evaluated the rates of early ischaemic recurrence after an acute ischaemic stroke in patients with paroxysmal atrial fibrillation or sustained atrial fibrillation which included persistent and permanent atrial fibrillation. In patients with acute ischaemic stroke, atrial fibrillation was categorised as paroxysmal atrial fibrillation or sustained atrial fibrillation. Ischaemic recurrences were the composite of ischaemic stroke, transient ischaemic attack and symptomatic systemic embolism occurring within 90 days from acute index stroke. A total of 2150 patients (1155 females, 53.7%) were enrolled: 930 (43.3%) had paroxysmal atrial fibrillation and 1220 (56.7%) sustained atrial fibrillation. During the 90-day follow-up, 111 ischaemic recurrences were observed in 107 patients: 31 in patients with paroxysmal atrial fibrillation (3.3%) and 76 with sustained atrial fibrillation (6.2%) (hazard ratio (HR) 1.86 (95% CI 1.24-2.81)). Patients with sustained atrial fibrillation were on average older, more likely to have diabetes mellitus, hypertension, history of stroke/ transient ischaemic attack, congestive heart failure, atrial enlargement, high baseline NIHSS-score and implanted pacemaker. After adjustment by Cox proportional hazard model, sustained atrial fibrillation was not associated with early ischaemic recurrences (adjusted HR 1.23 (95% CI 0.74-2.04)). After acute ischaemic stroke, patients with sustained atrial fibrillation had a higher rate of early ischaemic recurrence than patients with paroxysmal atrial fibrillation. After adjustment for relevant risk factors, sustained atrial fibrillation was not associated with a significantly higher risk of recurrence, thus suggesting that the risk profile associated with atrial fibrillation, rather than its pattern, is determinant for recurrence.

Sections du résumé

BACKGROUND BACKGROUND
The relationship between different patterns of atrial fibrillation and early recurrence after an acute ischaemic stroke is unclear.
PURPOSE OBJECTIVE
In a prospective cohort study, we evaluated the rates of early ischaemic recurrence after an acute ischaemic stroke in patients with paroxysmal atrial fibrillation or sustained atrial fibrillation which included persistent and permanent atrial fibrillation.
METHODS METHODS
In patients with acute ischaemic stroke, atrial fibrillation was categorised as paroxysmal atrial fibrillation or sustained atrial fibrillation. Ischaemic recurrences were the composite of ischaemic stroke, transient ischaemic attack and symptomatic systemic embolism occurring within 90 days from acute index stroke.
RESULTS RESULTS
A total of 2150 patients (1155 females, 53.7%) were enrolled: 930 (43.3%) had paroxysmal atrial fibrillation and 1220 (56.7%) sustained atrial fibrillation. During the 90-day follow-up, 111 ischaemic recurrences were observed in 107 patients: 31 in patients with paroxysmal atrial fibrillation (3.3%) and 76 with sustained atrial fibrillation (6.2%) (hazard ratio (HR) 1.86 (95% CI 1.24-2.81)). Patients with sustained atrial fibrillation were on average older, more likely to have diabetes mellitus, hypertension, history of stroke/ transient ischaemic attack, congestive heart failure, atrial enlargement, high baseline NIHSS-score and implanted pacemaker. After adjustment by Cox proportional hazard model, sustained atrial fibrillation was not associated with early ischaemic recurrences (adjusted HR 1.23 (95% CI 0.74-2.04)).
CONCLUSIONS CONCLUSIONS
After acute ischaemic stroke, patients with sustained atrial fibrillation had a higher rate of early ischaemic recurrence than patients with paroxysmal atrial fibrillation. After adjustment for relevant risk factors, sustained atrial fibrillation was not associated with a significantly higher risk of recurrence, thus suggesting that the risk profile associated with atrial fibrillation, rather than its pattern, is determinant for recurrence.

Identifiants

pubmed: 31165095
doi: 10.1177/2396987318785853
pii: 10.1177_2396987318785853
pmc: PMC6533867
doi:

Types de publication

Journal Article

Langues

eng

Pagination

55-64

Références

J Am Coll Cardiol. 2000 Jan;35(1):183-7
pubmed: 10636278
Stroke. 2001 Jun;32(6):1318-22
pubmed: 11387493
J Cardiovasc Electrophysiol. 2003 Apr;14(4):443-5
pubmed: 12741724
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61
pubmed: 18036454
J Intern Med. 2008 Jul;264(1):50-61
pubmed: 18266660
Eur Heart J. 2008 Apr;29(7):915-22
pubmed: 18334476
Stroke. 2008 Aug;39(8):2249-56
pubmed: 18535273
Eur Heart J. 2010 Apr;31(8):967-75
pubmed: 19176537
Int J Cardiol. 2013 Aug 20;167(4):1519-23
pubmed: 22609009
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):632-9
pubmed: 22787011
Int J Cardiol. 2013 Sep 10;167(6):2682-7
pubmed: 22795403
BMC Cardiovasc Disord. 2013 Apr 15;13:28
pubmed: 23586654
Eur Heart J. 2013 Aug;34(31):2464-71
pubmed: 23594592
Am J Cardiol. 2013 Oct 15;112(8):1142-7
pubmed: 23831166
Eur Heart J. 2013 Sep;34(35):2746-51
pubmed: 23900699
J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76
pubmed: 24685669
Circ J. 2014;78(10):2388-93
pubmed: 25099606
Eur Heart J. 2015 Feb 1;36(5):281-7a
pubmed: 25187524
Eur Heart J. 2015 Feb 1;36(5):288-96
pubmed: 25209598
Eur J Neurol. 2015 Aug;22(8):1215-9
pubmed: 25962447
Stroke. 2015 Aug;46(8):2175-82
pubmed: 26130094
Stroke. 2015 Sep;46(9):2523-8
pubmed: 26205373
Stroke. 2015 Dec;46(12):3354-61
pubmed: 26514188
Medicine (Baltimore). 2015 Dec;94(52):e2364
pubmed: 26717376
Europace. 2016 May;18(5):648-57
pubmed: 26826133
Stroke. 2016 Oct;47(10):2582-8
pubmed: 27531346
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465
J Am Heart Assoc. 2017 Nov 29;6(12):null
pubmed: 29220330

Auteurs

Maurizio Paciaroni (M)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Filippo Angelini (F)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Giancarlo Agnelli (G)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Georgios Tsivgoulis (G)

Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.
Department of Neurology, University of Tennessee Health Sciences Center, Memphis, TN, USA.

Karen L Furie (KL)

Division of Stroke and Cerebrovascular Diseases, Department of Neurology, The Warren Alpert Medical School of Brown University, Providence, RI, USA.

Prasanna Tadi (P)

Division of Stroke and Cerebrovascular Diseases, Department of Neurology, The Warren Alpert Medical School of Brown University, Providence, RI, USA.

Cecilia Becattini (C)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Nicola Falocci (N)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Marialuisa Zedde (M)

Neurology Unit, Stroke Unit, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy.

Azmil H Abdul-Rahim (AH)

Medical School and Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Kennedy R Lees (KR)

Medical School and Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Andrea Alberti (A)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Michele Venti (M)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Monica Acciarresi (M)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Riccardo Altavilla (R)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Cataldo D'Amore (C)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Maria G Mosconi (MG)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Ludovica A Cimini (LA)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Paolo Bovi (P)

SSO Stroke Unit, UO Neurologia, DAI di Neuroscienze, AOUI, Verona, Italy.

Monica Carletti (M)

SSO Stroke Unit, UO Neurologia, DAI di Neuroscienze, AOUI, Verona, Italy.

Alberto Rigatelli (A)

SSO Stroke Unit, UO Neurologia, DAI di Neuroscienze, AOUI, Verona, Italy.

Manuel Cappellari (M)

SSO Stroke Unit, UO Neurologia, DAI di Neuroscienze, AOUI, Verona, Italy.

Jukka Putaala (J)

Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.

Liisa Tomppo (L)

Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.

Turgut Tatlisumak (T)

Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland.
Department of Clinical Neurosciences, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg and Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Fabio Bandini (F)

Department of Neurology, Ospedale San Paolo, Savona, Italy.

Simona Marcheselli (S)

Neurologia d'urgenza e Stroke Unit, Istituto Clinico Humanitas, Rozzano, Milano, Italy.

Alessandro Pezzini (A)

Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia, Italy.

Loris Poli (L)

Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia, Italy.

Alessandro Padovani (A)

Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Brescia, Italy.

Luca Masotti (L)

Internal Medicine, Santa Maria Nuova Hospital, Firenze, Italy.

Vieri Vannucchi (V)

Internal Medicine, Santa Maria Nuova Hospital, Firenze, Italy.

Sung-Il Sohn (SI)

Department of Neurology, Keimyung University School of Medicine, Daegu, South Korea.

Gianni Lorenzini (G)

SC di Medicina e Chirurgia d'Accettazione e d'Urgenza degli ospedali di Pontedera e Volterra, Pontedera e Volterra, Italy.

Rossana Tassi (R)

Stroke Unit, AOU Senese, Siena, Italy.

Francesca Guideri (F)

Stroke Unit, AOU Senese, Siena, Italy.

Maurizio Acampa (M)

Stroke Unit, AOU Senese, Siena, Italy.

Giuseppe Martini (G)

Stroke Unit, AOU Senese, Siena, Italy.

George Ntaios (G)

Department of Medicine, University of Thessaly, Larissa, Greece.

Efstathia Karagkiozi (E)

Department of Medicine, University of Thessaly, Larissa, Greece.

George Athanasakis (G)

Department of Medicine, University of Thessaly, Larissa, Greece.

Kostantinos Makaritsis (K)

Department of Medicine, University of Thessaly, Larissa, Greece.

Kostantinos Vadikolias (K)

Department of Neurology, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.

Chrysoula Liantinioti (C)

Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.

Maria Chondrogianni (M)

Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.

Nicola Mumoli (N)

Department of Internal Medicine, Ospedale Civile di Livorno, Livorno, Italy.

Domenico Consoli (D)

Stroke Unit, Jazzolino Hospital, Vibo Valentia, Italy.

Franco Galati (F)

Stroke Unit, Jazzolino Hospital, Vibo Valentia, Italy.

Simona Sacco (S)

Department of Neurology, University of L'Aquila, Avezzano Hospital, Avezzano, Italy.

Antonio Carolei (A)

Department of Neurology, University of L'Aquila, Avezzano Hospital, Avezzano, Italy.

Cindy Tiseo (C)

Department of Neurology, University of L'Aquila, Avezzano Hospital, Avezzano, Italy.

Francesco Corea (F)

UO Gravi Cerebrolesioni, San Giovanni Battista Hospital, Foligno, Italy.

Walter Ageno (W)

Department of Internal Medicine, Insubria University, Varese, Italy.

Marta Bellesini (M)

Department of Internal Medicine, Insubria University, Varese, Italy.

Giorgio Silvestrelli (G)

SC di Neurologia e S.S. di Stroke Unit, ASST di Mantova, Mantova, Italy.

Alfonso Ciccone (A)

SC di Neurologia e S.S. di Stroke Unit, ASST di Mantova, Mantova, Italy.

Umberto Scoditti (U)

Stroke Unit, Neuroscience Department, University of Parma, Parma, Italy.

Licia Denti (L)

Stroke Unit, Dipartimento Geriatrico Riabilitativo, University of Parma, Parma, Italy.

Michelangelo Mancuso (M)

Clinica Neurologica, Azienda Ospedaliero-Universitaria, Pisa, Italy.

Miriam Maccarrone (M)

Clinica Neurologica, Azienda Ospedaliero-Universitaria, Pisa, Italy.

Giovanni Orlandi (G)

Clinica Neurologica, Azienda Ospedaliero-Universitaria, Pisa, Italy.
Neurologia, Ospedale Apuano, Massa Carrara, Italy.

Nicola Giannini (N)

Clinica Neurologica, Azienda Ospedaliero-Universitaria, Pisa, Italy.

Gino Gialdini (G)

Clinica Neurologica, Azienda Ospedaliero-Universitaria, Pisa, Italy.

Tiziana Tassinari (T)

Stroke Unit, Department of Neurology, Santa Corona Hospital, Pietra Ligure, Savona, Italy.

Maria Luisa De Lodovici (ML)

Stroke Unit, Neurology, Insubria University, Varese, Italy.

Giorgio Bono (G)

Stroke Unit, Neurology, Insubria University, Varese, Italy.

Christina Rueckert (C)

Abteilung für Neurologie, Oberschwabenklinik gGmbH, Ravensburg, Germany.

Antonio Baldi (A)

Stroke Unit, Ospedale di Portogruaro, Portogruaro, Venice, Italy.

Danilo Toni (D)

Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.

Federica Letteri (F)

Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.

Martina Giuntini (M)

Neurologia, Ospedale Apuano, Massa Carrara, Italy.

Enrico M Lotti (EM)

UO Neurologia Presidio Ospedaliero di Ravenna Azienda USL della Romagna, Ravenna, Italy.

Yuriy Flomin (Y)

Stroke and Neurorehabilitation Unit MC 'Universal Clinic 'Oberig', Kyiv, Ukraine.

Alessio Pieroni (A)

Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.

Odysseas Kargiotis (O)

Stroke Unit, Metropolitan Hospital, Piraeus, Greece.

Theodore Karapanayiotides (T)

2nd Department of Neurology, AHEPA University Hospital, Thessaloniki, Greece.

Serena Monaco (S)

Stroke Unit, Ospedale Civico, Palermo, Italy.

Mario M Baronello (MM)

Stroke Unit, Ospedale Civico, Palermo, Italy.

Laszló Csiba (L)

Stroke Unit, University of Debrecen, Debrecen, Hungary.

Lilla Szabó (L)

Stroke Unit, University of Debrecen, Debrecen, Hungary.

Alberto Chiti (A)

Stroke Unit, Department of Neurology, Sant'Andrea Hospital, La Spezia, Italy.
Clinica Neurologica, Azienda Ospedaliero-Universitaria, Pisa, Italy.

Elisa Giorli (E)

Stroke Unit, Department of Neurology, Sant'Andrea Hospital, La Spezia, Italy.

Massimo Del Sette (MD)

Stroke Unit, Department of Neurology, Sant'Andrea Hospital, La Spezia, Italy.
Divisione di Neurologia, Ospedale Galliera, Genoa, Italy.

Davide Imberti (D)

Department of Internal Medicine, Ospedale Civile di Piacenza, Italy.

Dorjan Zabzuni (D)

Department of Internal Medicine, Ospedale Civile di Piacenza, Italy.

Boris Doronin (B)

Municipal Budgetary Healthcare Institution of Novosibirsk, City Clinical Hospital n° 1, Novosibirsk State Medical University, Novosibirsk, Russia.

Vera Volodina (V)

Municipal Budgetary Healthcare Institution of Novosibirsk, City Clinical Hospital n° 1, Novosibirsk State Medical University, Novosibirsk, Russia.

Patrik Michel Pd-Mer (P)

Centre Cérébrovasculaire, Service de Neurologie, Département des Neurosciences Cliniques Centre Hopitalier Universitaire Vaudois, Lausanne, Switzerland.

Peter Vanacker (P)

Department of Neurology, Born Bunge Institute, Antwerp University Hospital, Antwerp, Belgium.

Kristian Barlinn (K)

Department of Neurology, Dresden University Stroke Center, Dresden, Germany.

Lars P Pallesen (LP)

Department of Neurology, Dresden University Stroke Center, Dresden, Germany.

Jessica Kepplinger (J)

Department of Neurology, Dresden University Stroke Center, Dresden, Germany.

Dirk Deleu (D)

Neurology, Hamad Medical Corporation, Doha, Qatar.

Gayane Melikyan (G)

Neurology, Hamad Medical Corporation, Doha, Qatar.

Faisal Ibrahim (F)

Neurology, Hamad Medical Corporation, Doha, Qatar.

Naveed Akhtar (N)

Neurology, Hamad Medical Corporation, Doha, Qatar.

Vanessa Gourbali (V)

Department of Neurology, Evangelismos Hospital, Athens, Greece.

Shadi Yaghi (S)

Division of Stroke and Cerebrovascular Diseases, Department of Neurology, The Warren Alpert Medical School of Brown University, Providence, RI, USA.

Valeria Caso (V)

Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Classifications MeSH